Legal & General Group’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-362
Closed -$6.28K 3421
2024
Q1
$6.28K Hold
362
﹤0.01% 3270
2023
Q4
$4.64K Hold
362
﹤0.01% 3330
2023
Q3
$13.4K Sell
362
-3,682
-91% -$136K ﹤0.01% 3192
2023
Q2
$163K Buy
4,044
+3,438
+567% +$138K ﹤0.01% 2779
2023
Q1
$44K Sell
606
-2,607
-81% -$189K ﹤0.01% 2898
2022
Q4
$263K Hold
3,213
﹤0.01% 2513
2022
Q3
$304K Buy
3,213
+95
+3% +$8.99K ﹤0.01% 2472
2022
Q2
$607K Buy
3,118
+76
+2% +$14.8K ﹤0.01% 2299
2022
Q1
$707K Buy
3,042
+41
+1% +$9.53K ﹤0.01% 2310
2021
Q4
$1.18M Buy
3,001
+690
+30% +$272K ﹤0.01% 2200
2021
Q3
$1.04M Buy
2,311
+561
+32% +$251K ﹤0.01% 2241
2021
Q2
$680K Sell
1,750
-57
-3% -$22.1K ﹤0.01% 2284
2021
Q1
$649K Sell
1,807
-389
-18% -$140K ﹤0.01% 2266
2020
Q4
$1.08M Buy
2,196
+712
+48% +$350K ﹤0.01% 2090
2020
Q3
$481K Sell
1,484
-32
-2% -$10.4K ﹤0.01% 2204
2020
Q2
$552K Buy
1,516
+100
+7% +$36.4K ﹤0.01% 2148
2020
Q1
$302K Sell
1,416
-99
-7% -$21.1K ﹤0.01% 2194
2019
Q4
$624K Buy
1,515
+677
+81% +$279K ﹤0.01% 2181
2019
Q3
$296K Buy
838
+130
+18% +$45.9K ﹤0.01% 2272
2019
Q2
$356K Buy
708
+28
+4% +$14.1K ﹤0.01% 2211
2019
Q1
$675K Buy
680
+8
+1% +$7.94K ﹤0.01% 2089
2018
Q4
$584K Buy
672
+39
+6% +$33.9K ﹤0.01% 2080
2018
Q3
$655K Buy
633
+376
+146% +$389K ﹤0.01% 2073
2018
Q2
$237K Buy
257
+9
+4% +$8.3K ﹤0.01% 2265
2018
Q1
$243K Sell
248
-5
-2% -$4.9K ﹤0.01% 2259
2017
Q4
$110K Sell
253
-27
-10% -$11.7K ﹤0.01% 2534
2017
Q3
$115K Buy
280
+42
+18% +$17.3K ﹤0.01% 2570
2017
Q2
$85K Hold
238
﹤0.01% 2682
2017
Q1
$120K Sell
238
-4
-2% -$2.02K ﹤0.01% 2448
2016
Q4
$86K Buy
242
+99
+69% +$35.2K ﹤0.01% 2657
2016
Q3
$75K Hold
143
﹤0.01% 2327
2016
Q2
$80K Buy
143
+44
+44% +$24.6K ﹤0.01% 2210
2016
Q1
$49K Hold
99
﹤0.01% 2420
2015
Q4
$63K Hold
99
﹤0.01% 2333
2015
Q3
$82K Hold
99
﹤0.01% 2153
2015
Q2
$130K Buy
+99
New +$130K ﹤0.01% 1942